Clinical Trial: Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06820424) titled 'Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors' on Feb. 06.

Brief Summary: This is a single-center, open-label, single-arm study to evaluate the safety and preliminary efficacy of anti-CDH17 CAR-T cells in patients with CDH17-positive advanced solid tumors.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: CDH17-positive Advanced Solid Tumors

Intervention: BIOLOGICAL: Anti-CDH17 CAR-T cells infusion

Subiects who meet the enrollment conditions will receive intravenous infusion of anti-CDH17 CAR-T Cells after lymphodepleting therapy.

Recr...